B. Paul-Roc

Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting.

M. Jaramillo, Zully Leon, S. Grothé, 2006, Experimental cell research.

Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX

S. C. Chafe, F. Bénard, M. Jaramillo, 2021, mAbs.

Differential sensitivity of A549 non small lung carcinoma cell responses to epidermal growth factor receptor pathway inhibitors

M. Jaramillo, M. O’Connor-McCourt, C. Collins, 2008, Cancer biology & therapy.

Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies

M. O’Connor-McCourt, A. Lenferink, A. Nantel, 2010, Oncogene.

Engineering and Therapeutic Application of Single-Chain Bivalent TGF-β Family Traps

M. O’Connor-McCourt, A. Lenferink, C. Collins, 2012, Molecular Cancer Therapeutics.

Molecular imaging of breast tumors using a near‐infrared fluorescently labeled clusterin binding peptide

Feng Ni, Ping Xu, Christiane Cantin, 2012, International journal of cancer.

Optimization of a high-cell-density polyethylenimine transfection method for rapid protein production in CHO-EBNA1 cells.

Yves Durocher, Jason Baardsnes, J. Baardsnes, 2018, Journal of biotechnology.

Abstract 1467: AB-16B5, a therapeutic monoclonal antibody against human clusterin that blocks the epithelial-to-mesenchymal transition

M. O’Connor-McCourt, A. Lenferink, T. Sulea, 2010 .